EE425 Cost-Effectiveness Analysis of Rivaroxaban Vs Other Anticoagulants
Jul 1, 2022, 00:00 AM
10.1016/j.jval.2022.04.673
https://www.valueinhealthjournal.com/article/S1098-3015(22)00874-9/fulltext
Section Title :
Section Order :
10603
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00874-9&doi=10.1016/j.jval.2022.04.673